Respiro Diagnostics
Develops breath-based diagnostic platform for lung cancer and respiratory diseases
£1MPre-Seed
Role not disclosedIU
Innovate UK
Activity from announced rounds
Activity in this selectionJul 31, 2026 · Jul 1, 2026
Innovate UK is the innovation agency identified as a grant backer by Respiro Diagnostics and through its Investor Partnerships Programme by Adaptavate.
Recorded funding activity
Adaptavate develops lower-carbon building materials. Other recorded companies include Productive Machines’ CNC setup software and Athernal’s targeted therapies for high-risk blood conditions. Grant and investment-program participation must retain the instrument stated in each announcement.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $1.3M 1 disclosed · full round size, not this investor’s share